Redmile Biopharma Investments I, L.P.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2018-07-277/27/18 | Amended | $218,270,000 | $141,064,787 | Other | 06b 3C 3C.1 3C.7 | SEC linkSEC |
| 2017-07-287/28/17 | Amended | $77,205,213 | $47,205,213 | Other | 06b 3C 3C.7 | SEC linkSEC |
| 2016-07-287/28/16 | Amended | $30,000,000 | $30,000,000 | Other | 06b 3C 3C.1 3C.7 | SEC linkSEC |
| 2015-07-287/28/15 | New | Yet to Sell | $0 | Other | 06b 3C 3C.1 3C.7 | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Jonathan Forman | Promoter |
| Jeremy Green | Promoter |
| Mike Lee | Promoter |
| Amrit Nagpal | Promoter |
| N/A N/A Redmile Biopharma Investments I (Gp), Llc | Promoter |
| General Partner Redmile Biopharma Investments I (Gp), Llc | Promoter |
| N/A N/A Redmile Biotechnologies Investments I (Gp), Llc | Promoter |
| N/A N/A Redmile Group, Llc | Promoter |
| Managing Mbr Of The Gp Of The Issuer Redmile Group, Llc | Promoter |
Industry: Pooled Investment Fund (See others in industry)
Address:
One Letterman Drive, Building D Suite D3 300
San Francisco, CA, 94129
Phone: 415-489-9980
San Francisco, CA, 94129
Phone: 415-489-9980